Provider
QP37-26 Commercial Pharmacy Benefit Exclusion for Epioxa™ HD/Epioxa, Fensolvi®, Fesilty™, Midazolam, Photrexa®, Wainua®, Zemaira®, and Zoladex®
Program effective Date: May 27, 2026
Search Results
Displaying 4271 - 4274 of 4274 results
Provider
QP36-26 Commercial Pharmacy Benefit Exclusion for Select Medications
Program effective Date: May 27, 2026
Provider
QP35-26 Intensive Residential Treatment Services (IRTS) Prior Authorization (PA) Requirements
Program effective Date: May 27, 2026
Provider
QP34-26 Billing Changes for Opioid Treatment Programs for Minnesota Health Care Programs
Program effective Date: May 27, 2026